2010 BC Guide in Determining Fitness to Drive

11.7 Private and commercial drivers with Type 2 diabetes that is treated withinsulin secretagoguesApplicationAssessment guidelinesFitness guidelinesOSMV determinationguidelinesConditionsThese guidelines apply to driver fitness determinations for private andcommercial drivers with Type 2 diabetes treated with insulin secretagogues,including: glyburide (generic or under brand names DiaBeta and Euglucon) gliclazide (generic or under brand names Diamicron and Diamicron MR) glimpiride (brand name Amaryl) repaglinide (brand name GlucoNorm), and nateglinide (brand name Starlix).If the individual has had an episode of severe hypoglycemia within the pastsix months, see the guidelines for private drivers under 11.10 andcommercial drivers under 11.13.If further information is required, OSMV will request: a Driver’s Medical Examination Report, or additional information from the treating physician.Individuals may drive if they: have a good understanding of their condition routinely follow their physician’s instructions about diet, medication,glucose monitoring and the prevention of hypoglycemia remain under regular medical supervision to ensure that any progressionin their condition or development of chronic complications does not gounattended stop driving and treat themselves immediately if hypoglycemia isidentified or suspected do not drive until a least 45 minutes after effective treatment if theirblood glucose is between 2.5 and 4.0 mmol/L, and report to OSMV if they begin insulin therapyOSMV may find individuals fit to drive if they: have a good understanding of their condition, and routinely follow their physician’s instructions about diet, medication,glucose monitoring and the prevention of hypoglycemia.OSMV will impose the following conditions on an individual who is foundfit to drive: you must report to OSMV if you begin insulin therapy you must report to OSMV and your physician if you have an episode ofsevere hypoglycemia you must remain under regular medical supervision to ensure that anyprogression in your condition or development of chronic complicationsdoes not go unattended you must stop driving and treat yourself immediately if hypoglycemia isidentified or suspected, and you must not drive until at least 45 minutes after effective treatment ifyour blood glucose is between 2.5 and 4.0 mmol/L.91